Elekta AB (Elekta AB) Research & Development : $128 Mil (TTM As of Jan. 2024)

View and export this data going back to . Start your Free Trial

What is Elekta AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Elekta AB's Research & Development for the three months ended in Jan. 2024 was $33 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2024 was $128 Mil.

Elekta AB Research & Development Historical Data

The historical data trend for Elekta AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elekta AB Research & Development Chart

Elekta AB Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Research & Development

Get a 7-Day Free Trial

170.67

165.43

174.84

143.54

137.03

Elekta AB Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Research & Development	Get a 7-Day Free Trial															35.01	29.47	36.76	29.30	32.92

Elekta AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $128 Mil.

Elekta AB (OTCPK:EKTAF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Elekta AB Research & Development Related Terms

Thank you for viewing the detailed overview of Elekta AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Elekta AB (Elekta AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (OTCPK:EKTAF) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

EKTAY:USA EKTA B:Sweden EKTAB:Mexico EKTABs:UK 0O5H:UK EJXB:Germany

Address

Kungstensgatan 18, Box 7593, Stockholm, SWE, SE-103 93

Website

https://www.elekta.com

Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company's installed base of more than 5,000 linear accelerators, GammaKnife and Unity platforms, and software is used in more than 6,000 hospitals globally. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and Asia-Pacific contributing the remainder.